Turning science into healthcare
Genomics England aims to help everyone benefit from genomic healthcare.
Leadership Team
The Executive Leadership Team works alongside the Board of Directors to set and influence our strategic direction, while providing leadership both within the organisation and externally, as ambassadors and thought leaders.
Dr Richard Scott
Chief Executive Officer
Dr Ellen Thomas
Interim Chief Medical Officer
Professor Matt Brown
Chief Scientific Officer
Catherine Byers
Chief Financial and Performance Officer
Jackie Kinsey
Chief People Officer
Nick Maltby
General Counsel, Company Secretary and Data Protection Officer
Rakhi Rajani
Chief Digital and Strategy Officer
Dr Augusto Rendon
Chief Bioinformatician
Pete Sinden
Chief Information Officer
Chris Schonewald
Chief of Staff and Director of Strategy
Board
The Genomics England Board oversees all of our activities, ratifies all major decisions and sets the overall strategy for the organisation. Genomics England has several independent advisory committees that report to the board. These include the Ethics Advisory Committee, Science Advisory Committee, Data Advisory Committee, Access Review Committee, GeCIP Board and the Audit Committee.
Dr Richard Scott
Chief Executive Officer
Baroness Nicola Blackwood
Chair
Dr Vikram Bajaj
Non-Executive Director
Professor Sir John Bell
Non-Executive Director, Chair of Scientific Advisory Committee
Professor Ewan Birney
Non-Executive Director
Professor Matt Brown
Chief Scientific Officer
Roz Campion
Director, Office for Life Sciences
Dr Annalisa Jenkins
Non-Executive Director
Nicola Perrin MBE
Non-Executive Director
Dr Keith Stewart
Non-Executive Director
Sir Jonathan Symonds CBE
Non-Executive Director
Participant Panel
The Participant Panel sits at the heart of Genomics England and is made up of participants from the 100,000 Genomes Project, and parents or carers of people involved in this project. It is expanding to include patients and relatives from the GenOMICC COVID-19 study and NHS patients who give consent for their whole genome sequences and associated health data to be used for research in the Genomics England National Genomic Research Library.
The Panel acts as an advisory body to the Genomics England Board, working to ensure that the health data held by Genomics England is being looked after with respect and used in the best interests of our participants.
Jillian Hastings Ward
Chair of the Participant Panel
Rebecca Middleton
Vice Chair for Rare Conditions
Helen White
Vice Chair for Cancer
Frances Allan
Participant Panel member
Paul Arvidson
Participant Panel member
Lisa Beaton
Participant Panel member
Cecily Berryman
Participant Panel member
Dr Helen Bulbeck
Participant Panel member
Dr Latha Chandramouli
Participant Panel member
Mel Dixon
Participant Panel member
Alison Fox
Participant Panel member
Clarissa Hopkins
Participant Panel member
Hannah Humphrey
Participant Panel member
Ismael Kherroubi García
Participant Panel member
Anthony Locke
Participant Panel member
Dave McCormick
Participant Panel member
Helen Mendis
Participant Panel member
Hannah Podd
Participant Panel Member
Shelley Simmonds
Participant Panel member
Dominique Stephens
Participant Panel member
Emma Walters
Participant Panel member
Science Advisory Committee
Our independent Science Advisory Committee advises the Genomics England Board on scientific aspects of the company's projects. This includes overseeing: disease inclusion criteria; Genomics England Clinical Interpretation Partnership (GeCIP) domain formation; data access request applications; and patient recruitment strategies. The Committee considers the interests of patients, the public, scientists and clinicians engaged in genomic research or genomic medicine.
Professor Sir John Bell
Non-Executive Director, Chair of Scientific Advisory Committee
Professor Tim Aitman
University of Edinburgh
James Brenton
Cancer Research UK Cambridge Institute
Professor Sir John Burn
Newcastle University
Professor Patrick Chinnery
University of Cambridge
David Church
Andrew Fry
Professor Dame Sue Hill
NHS England
Professor Matthew Hurles
Wellcome Sanger Institute
Professor Mark Lawler
HDR UK
Professor David Lomas
Deputy Chair, Scientific Advisory Committee
Professor Anna Schuh
University of Oxford
Professor Matt Seymour
University of Leeds
Dr Samra Turajlic
Cancer Research UK
Professor Andrew Wilkie
University of Oxford
Ethics Advisory Committee
Our independent Ethics Advisory Committee identifies, defines, examines and responds to ethical issues in the 100,000 Genomes Project. They also help to ensure the Project is delivered in the interests of the public and of participants.
They provide timely advice, guidance, review and recommendations on ethical issues, as requested by the Board.
Dr Latha Chandramouli
Participant Panel member
Professor Sir Jonathan Montgomery
Chair of the Ethics Advisory Committee
Francis Crawley
Executive Director, Good Clinical Practice Alliance
Professor Angus Clarke
Cardiff University
Anne Croudass
Cancer Research UK
Professor Adam Hedgecoe
Professor of Social Science, Cardiff University
Associate Professor Ruth Horn
Associate Professor in Ethics, Ethox
Hannah Humphrey
Participant Panel member
Ismael Kherroubi García
Participant Panel member
Dr Mavis Machirori
Senior Researcher, Ada Lovelace Institute
Dr Pete Mills
Executive Director at the PHG Foundation
Nicola Perrin MBE
Non-Executive Director
Dr Nadeem Qureshi
University of Nottingham
Professor Rameen Shakur
Professor of Genomics and Precision Cardiovascular Medicine
Nechama Wieder
PhD Candidate in Clinical Medicine, University of Oxford
Access Review Committee
The Access Review Committee’s (ARC) role is to provide an independent examination and response to requests for access to genomic and health data held in the Genomics England National Genomic Research Library. These requests come from academic researchers, clinicians, and commercial researchers.
There is a set application process for these individuals to go through to access the data. The ARC reviews these applications to check that they are in line with the aims of the National Genomic Research Library Protocol and to assess whether they are in the interest of both the public and the participants.
Dr Christine Patch
Chair of the Access Review Committee
Natasha Dunkley
Head of Digital Strategy, Welsh Government
Jillian Hastings Ward
Chair of the Participant Panel
Helen White
Vice Chair for Cancer
Clarissa Hopkins
Participant Panel member
Hannah Podd
Participant Panel Member
Dr Simon Stockley
General Practitioner
Dr Shereen Tadros
Consultant in Clinical Genetics, GOSH
Danielle Wilson
Centre and Research Commercialisation Manager, Imperial College
Research Network Committee
The Research Network Committee oversees the operation of the Research Network and includes a range of representatives from across the Research Network communities. Three places on the Research Network Committee are reserved for the representatives of the Participant Panel and they contribute and vote as any other member of the Research Network Committee. The individual Participant Panel representatives are free to rotate attendance at the Research Network Committee according to their availability.
Professor Eamonn Sheridan
Chair of the Research Network Committee
Dr Helen Bulbeck
Participant Panel member
Professor Dame Sue Hill
NHS England
Dave McCormick
Participant Panel member
Helen Mendis
Participant Panel member
Professor John Sayer
Deputy Chair and Research representative
Dr Nicky Whiffin
Quantitative Genomics representative
Dr Catherine Taylor
Clinical representative
Dr Letizia Vestito
Early Career Researcher representative
Professor Claude Chelala
Data Science representative
Dr William Macken
Early Career Researcher representative
Research Network Community Leads
Our Research Network Community Leads spearhead, represent and advise the 8 cross-functional communities that make up our Research Network. Championing their respective community interests, the leads engage with Genomics England to identify strategic research and funding opportunities.
The Community Leads drive collaborations, skill-sharing and meaningful interactions between members of their communities, streamlining the way genomic research is carried out.
Professor Richard Houlston
Pan-Cancer and Molecular Oncology lead
Professor Anna Schuh
Pan-Cancer and Molecular Oncology co-lead
Professor Elijah Behr
Predisposition and Screening lead
Professor Sanjay Sisodiya
Predisposition and Screening co-lead
Professor Sophie Hambleton
Variant Discovery and Clinical Interpretation lead
Professor Caroline Wright
Variant Discovery and Clinical Interpretation co-lead
Professor Christopher Yau
Bioinformatics and Machine Learning lead
Dr David Morris
Bioinformatics and machine learning co-lead
Professor Daniel Gale
Therapeutic Innovations and Trials lead
Dr Haiyan Zhou
Therapeutic Innovations and Trials co-lead
Dr Aylwyn Scally
Population Genomics lead
Professor Jean-Baptiste Cazier
Population Genomics co-lead
Professor Amy Jayne McKnight
Implementation and Data Enhancement lead
Professor Diana Baralle
Genotype-Phenotype Association lead
Dr Gavin Arno
Genotype-Phenotype Association co-lead
